Of particular interest, Leptin, pro-inflammatory high-density lipoprotein, and TNF related weak inducer of apoptosis (TWEAK) have been reported as potential biomarkers of atherosclerosis in SLE in previous studies (10, 20–22). This evidence concerns the gene TNFSF12 and systemic lupus erythematosus.